References
- Higuchi S., Sasaki H., Shiobara Y., Sado T. Absorption, excretion and metabolism of a new dihydropyridine diester cerebral vasodilator in rats and dogs. Xenobiotica 1977; 7: 469–479
- Higuchi S., Shiobara Y. Metabolic fate of nicardipine hydrochloride, a new vasodilator, by various species in vitro. Xenobiotica 1980; 10: 889–896
- Ignarro L. J., Lipton H., Edwords J. C., Baricos W. H., Hymann A. L., Kadwitz P. Z., Gruetter C. A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide. Journal of Pharmacology and Experimental Therapeutics 1981; 218: 739–749
- Kobayashi Y., Okumura S., Kosaka Y., Kobayashi S., Inoue A., Oka T., Nakamizo N. Identification of benidipine hydrochloride metabolites in rats and dogs. Arzneimittel-Forschung 1988; 38: 1753–1756
- Medenwald H., Schlossman K., Wunsche C. Structuraufklarung der renalen ausscheidungsprodukte von 4-(2-nitrophenyl)-2, 6-dimethyl-1, 4-dihydropyridin-3, 5-di-carbonsaure-dimethylester. Arzneimittel-Forschung 1972; 22: 53–56
- Miyata N., Tsuchida K., Otomo S. Protein kinase C-mediated contraction in rabbit aorta is inhibited by CD-349, a dihydropyridine derivative. Journal of Cardiovascular Pharmacology 1991; 17: 786–791
- Ogawa T., Nakashima Y., Nakasato A., Kumazawa Y., Kawase M., Tsuchida K., Sota K. Synthesis and antihypertensive effect of the metabolites of 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(2-nitroxypropyl) ester 5-(3-nitroxypropyl) ester (CD-349)Presented at the Japanese-United States Congress of Pharmaceutical Sciences, Honolulu, Hawaii, December2–7, 1987
- Parinov V. J., Odinec A. G., Gilev A. P., Dubur G. J., Muceniece D. H., Ozol J. J., Shatz V. D., Gavars M. P., Vigante B. A. Pharmacokinetics and metabolism of ryodipine in rats. Arzneimittel- Forschung 1985; 35: 808–813
- Regardh C. G., Baarnhielm C., Edgar B., Hoffmann K.-J. Pharmacokinetics and biotransformation of 1,4-dihydropyridine calcium antagonists.Progress in Drug Metabolism, G. G. Gibson. Taylor & Francis, London 1990Vol. 12
- Scherling D., Karl W., Ahr G., Ahr H. J., Wehinger E. Pharmacokinetics of nisoldipine III. Biotransformation of nitrendipine in rat, dog, monkey and man. Arzneimittel-Forschung 1988; 38: 1105–1110
- Scherling D., Karl W., Ahr H. J., Kern A., Siefert H.-M. Biotransformation of nitrendipine in rat, dog and mouse. Arzneimittel-Forschung 1991; 41: 1009–1021
- Takayama F., Iwasawa Y., Saito K., Shiratori K., Ohtawa M. Metabolism of a new dihydropyridine calcium antagonist in rats and dogs. Xenobiotica 1989; 19: 1407–1420
- Taylor T., Taylor I. W., Chasseaud L. F., Bonn R. Pharmacokinetics and metabolism of organic nitrate vasodilatorsProgress in Drug Metabolism, J. W. Bridges, L. F. Chasseaud, G. G. Gibson. Taylor & Francis, London 1987Vol. 10
- Terashita S., Tokuma Y., Fujiwara T., Shiokawa Y., Okumura K., Noguchi H. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987; 14: 1415–1425
- Tsuchida K., Muramatsu M., Kaneko K., Yamazaki R., Yamada T., Ogawa N., Aihara H. CD-349. Cardiovascular Drug Reviews 1990; 8: 45–55
- Tsuchida K., Yamazaki R., Kaneko K., Aihara H. Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2, 6-dimethyl-4-(3-nitrophenyl)-1, 4-dihydropyridine-3, 5-di-carboxylate on cerebral circulation in dogs. Arzneimittel-Forschung 1987; 37: 1239–1243
- Weidolf L., Borg K. O., Hoffmann K.-J. Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat and mouse. Xenobiotica 1984; 14: 657–666
- Weidolf L., Hoffmann K.-J. Physico-chemical properties of urinary metabolites of felodipine, a new vasodilator drug. Acta Pharmaceutica Suecica 1984; 21: 331–344